Provided by Tiger Trade Technology Pte. Ltd.

Oculis

8.66
+0.16001.88%
Volume:452.01K
Turnover:3.88M
Market Cap:534.60M
PE:-5.05
High:8.75
Open:8.50
Low:8.37
Close:8.50
52wk High:34.48
52wk Low:8.30
Shares:61.73M
Float Shares:53.44M
Volume Ratio:1.21
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.03
PE(LYR):-3.63

Loading ...

Oculis Holding Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Summit Therapeutics (SMMT), Oculis Holding (OCS) and Cogent Biosciences (COGT)

TIPRANKS
·
Jun 01

Oculis price target lowered to $40 from $50 at Stifel

TIPRANKS
·
Jun 01

Oculis Maintained at Buy as Analyst Lowers Price Target to $45, Refocuses on Optic Neuritis Opportunity

TIPRANKS
·
Jun 01

Oculis Holding Ag : Leerink Partners Cuts Target Price to $40 From $50

THOMSON REUTERS
·
Jun 01

Analyst Maintains Buy on Oculis, Sees Upside Driven by Optic Neuropathy and Dry Eye Pipelines Despite OCS-01 Phase 3 Setback

TIPRANKS
·
Jun 01

Stocks to Watch: Oculis, Lisata, Healthy Choice Wellness

Dow Jones
·
May 30

Small U.S. Stocks Close Lower; Oculis Holding Takes Biggest Hit

Dow Jones
·
May 30

Oculis Shares Fall After Decision To Not Pursue FDA Approval For Eye Disease Treatment

Dow Jones
·
May 30

Oculis Holding AG Phase 3 Trial of Potential Eye Drops for Diabetic Patients Fails to Primary Endpoint

MT Newswires Live
·
May 30

Oculis reports primary endpoint of DIAMOND Phase 3 trials was not met

TIPRANKS
·
May 30

Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

GlobeNewswire
·
May 30

Oculis Holding AG trading halted, news pending

TIPRANKS
·
May 30

NASDAQ TRADE HALT HALT NEWS PENDING AT 02:43 PM

Reuters
·
May 30

Oculis quickly falls 26% to $22 per share

TIPRANKS
·
May 30

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
May 29

Oculis Holding Initiated at Buy by Guggenheim

Dow Jones
·
May 21

Guggenheim Initiates Oculis Holding at Buy With $75 Price Target

MT Newswires Live
·
May 21

Oculis initiated with a Buy at Guggenheim

TIPRANKS
·
May 21

Fujian Aims for Over 300 Billion Yuan in Photonics Cluster Revenue by 2030, Accelerates R&D on High-Speed Optical Modules

Deep News
·
May 19